Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys

Veterinary Research Communications

Volumn 20, Issue 5, 1996, Pages 469-472

  Cheng, Z ^a   McKellar, Q ^a   Nolan, A ^a   Lees, P ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Donkey; Flunixin; Pharmacokinetics; Prostaglandin; Thromboxane

Indexed keywords

FLUNIXIN MEGLUMINE; PLACEBO; CARRAGEENAN; CLONIXIN; DRUG DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DISPOSITION; DRUG TISSUE LEVEL; FEMALE; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PHARMACODYNAMICS; PHARMACOKINETICS; ANIMAL; CHEMICALLY INDUCED DISORDER; HORSE; METABOLIC CLEARANCE RATE; METABOLISM;

ANIMALIA; EQUUS ASINUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CLONIXIN; DINOPROSTONE; EQUIDAE; FEMALE; INFLAMMATION; METABOLIC CLEARANCE RATE;

EID: 0029658799     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00419184     Document Type: Article

References (13)

1. Anderson, D., 1988. Clinical use of flunixin. British Veterinary Journal, Supplement 1, 7-8
2. Higgins, A.J. and Lees, P., 1984. Arachidonic acid metabolites in carrageenan-induced equine inflammatory exudate. Journal of Veterinary Pharmacology and Therapeutics, 7, 65-72
3. Higgins, A.J., Lees, P. and Sedgwick, A.D., 1987. Development of equine models of inflammation. Veterinary Record, 120, 517-522
4. Kopcha, M. and Ahl, A.S., 1989. Experimental uses of flunixin meglumine and phenylbutazone in food producing animals. Journal of the American Veterinary Medical Association, 194, 45-49
5. Landoni, M.F., Cunningham, F.M. and Lees, P., 1995. Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modeling. American Journal of Veterinary Research, 56, 786-794
6. Lees, P., Higgins, A.J., Sedgwick, A.D. and May, S.A., 1987a. Applications of equine models of acute inflammation. Veterinary Record, 120, 522-529
7. Lees, P., Ewins, C.P., Taylor, B.O. and Sedgwick, A.D., 1987b. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin. British Veterinary Journal, 143, 462-476
8. McKellar, Q.A., Galbraith, E.A., Bogan, J.A., Russell, C.S., Hooke, R.E. and Lees, P., 1989. Flunixin pharmacokinetics and serum thromboxane inhibition in the dog. Veterinary Record, 124, 651-654
9. McKellar, Q.A., Lees, P. and Gettinby, G., 1994. Pharmacodynamics of tolfenamic acid in dogs. Evaluation of dose-response relationships. European Journal of Pharmacology, 253, 191-200
10. Selman, I., 1988. Experimental studies with flunixin meglumine. British Veterinary Journal, Supplement 1, 4-6
11. Semrad, S.D., Hardee, G.E., Hardee, M.M. and Moore, J.N., 1985. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. American Journal of Veterinary Research, 46, 2474-2497
12. Taylor, P.M., Winnard, J.G. and Lees, P., 1994. Flunixin in the cat: a pharmacokinetic and toxicological study. British Veterinary Journal, 150, 253-262
13. Welsh, E.M., McKellar, Q.A. and Nolan, A.M., 1993. The pharmacokinetics of flunixin meglumine in the sheep. Journal of Veterinary Pharmacology and Therapeutics, 16, 181-188